HOPA develops and publishes evidence-based and clinical practice tools and resources to help hematology/oncology pharmacist deliver the best possible cancer care for patients and their families. In collaboration with other nursing and affiliated professional organizations, HOPA is also pleased to share additional resources to help pharmacists optimize cancer care.


Scope of Hematology/Oncology Pharmacy Practice

A comprehensive document detailing the important role of the Hematology/Oncology Pharmacist in patient care.

View PDF: Scope of Hematology/Oncology Pharmacy Practice


HOPA Investigational Drug Service Best Practice Standards

The HOPA Investigational Drug Service Best Practice Standards is the first of its kind that provides the best practice standards and guidance for pharmacists and institutions that conduct clinical trials. This document emphasizes the critical role of the pharmacist in the investigational drug service from protocol concept to close-out. This document also provides a foundation for pharmacy to be involved very early in protocol development and review, to ensure that the trial meets institutional medication guidelines, is executed efficiently, and adheres to all regulations and standards.

View PDF: HOPA Investigational Drug Service Best Practice Standards

Position Statements

Dose Rounding of Biologic and Cytotoxic Anticancer Agents

A document intended to serve as a guideline during the development of a dose-rounding policy and to support and validate existing policies.

View PDF: Dose Rounding of Biologic and Cytotoxic Anticancer Agents.

Additional Resources

ONS Medical Surveillance Questionnaire

Medical surveillance programs are recommended to detect changes in the health status of those working with hazardous drugs. The Oncology Nursing Society (ONS) has developed a sample medical surveillance questionnaire that can be adapted to your healthcare setting. HOPA continues to work with ONS and other nursing and professional association representatives to share members’ concerns about safe handling of hazardous drugs and are partnering to encourage safety in health care.

View PDF: ONS Medical Surveillance Questionnaire

Time to Talk CINV

HOPA and Eisai have joined together to raise awareness about the impact of CINV to encourage and improve conversations about this treatment-related side effect between patients and their pharmacists. Here are some important resources about CINV to learn more about it. 

Advance Practitioner Certificate Programs

Three certificate programs are available for Advance Practitioners who work in oncology. The program is a collaborative effort between ASCO, APAO, APSHO, MEI, and HOPA. The program consists of 3 certificate programs comprised of 10 courses each. Topics include supportive care, common anti-cancer therapies, pain management, and immuno-oncology. HOPA members receive a 20% discount on the program. Visit ASCO University for more information.

AMCP Biosimilars Resource Center

The Academy of Managed Care Pharmacy (AMCP) offers the Biosimilars Resource Center (BRC) - an "unbiased, policy-neutral repository of educational resources and information on biosimilars for pharmacists, physicians, nurses, and other health care providers."

This frequently updated site includes a variety of educational materials including frequently asked questions, whitepapers, web-based seminars, continuing education programs, and journal articles.